The latest study on Acute Myeloid Leukemia (AML) Therapeutics Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Acute Myeloid Leukemia (AML) Therapeutics Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Acute Myeloid Leukemia (AML) Therapeutics and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Bristol-Myers Squibb
Novartis
Roche
Genmab
GlaxoSmithKline Pharmaceuticals
Acute Myeloid Leukemia (AML) Therapeutics Market Analysis By Type Segment:
Chemotherapy
Radiation therapy
Stem Cell Transplant
Targeted Therapy
Others
Acute Myeloid Leukemia (AML) Therapeutics Market Analysis By Application Segment:
Hospital
Retails Drug Stores
Ambulatory Care Centers
Oncology Centers
Clinics
Acute Myeloid Leukemia (AML) Therapeutics Market Analysis By Regions (Countries):
The Acute Myeloid Leukemia (AML) Therapeutics Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Acute Myeloid Leukemia (AML) Therapeutics Report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Acute Myeloid Leukemia (AML) Therapeutics Market:
Acute Myeloid Leukemia (AML) Therapeutics market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Acute Myeloid Leukemia (AML) Therapeutics Market status and future forecast.
To present the key Acute Myeloid Leukemia (AML) Therapeutics Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Growth Rate by Type (2016-2027)
1.4.2 Chemotherapy
1.4.3 Radiation therapy
1.4.4 Stem Cell Transplant
1.4.5 Targeted Therapy
1.4.6 Others
1.5 Market by Application
1.5.1 Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Application (2016-2027)
1.5.2 Hospital
1.5.3 Retails Drug Stores
1.5.4 Ambulatory Care Centers
1.5.5 Oncology Centers
1.5.6 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Acute Myeloid Leukemia (AML) Therapeutics Market Size
2.2 Acute Myeloid Leukemia (AML) Therapeutics Growth Trends by Regions
2.2.1 Acute Myeloid Leukemia (AML) Therapeutics Market Size by Regions (2016-2027)
2.2.2 Acute Myeloid Leukemia (AML) Therapeutics Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Acute Myeloid Leukemia (AML) Therapeutics Market Size by Manufacturers
3.1.1 Global Acute Myeloid Leukemia (AML) Therapeutics Revenue by Manufacturers (2020)
3.1.2 Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share by Manufacturers (2020)
3.1.3 Global Acute Myeloid Leukemia (AML) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Acute Myeloid Leukemia (AML) Therapeutics Key Players Head office and Area Served
3.3 Key Players Acute Myeloid Leukemia (AML) Therapeutics Product/Solution/Service
3.4 Date of Enter into Acute Myeloid Leukemia (AML) Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2016-2020)
4.2 Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2016-2020)
5 United States
5.1 United States Acute Myeloid Leukemia (AML) Therapeutics Market Size (2016-2020)
5.2 Acute Myeloid Leukemia (AML) Therapeutics Key Players in United States
5.3 United States Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type
5.4 United States Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application
6 Europe
6.1 Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size (2016-2020)
6.2 Acute Myeloid Leukemia (AML) Therapeutics Key Players in Europe
6.3 Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type
6.4 Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application
7 China
7.1 China Acute Myeloid Leukemia (AML) Therapeutics Market Size (2016-2020)
7.2 Acute Myeloid Leukemia (AML) Therapeutics Key Players in China
7.3 China Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type
7.4 China Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application
8 Japan
8.1 Japan Acute Myeloid Leukemia (AML) Therapeutics Market Size (2016-2020)
8.2 Acute Myeloid Leukemia (AML) Therapeutics Key Players in Japan
8.3 Japan Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type
8.4 Japan Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Market Size (2016-2020)
9.2 Acute Myeloid Leukemia (AML) Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type
9.4 Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application
10 India
10.1 India Acute Myeloid Leukemia (AML) Therapeutics Market Size (2016-2020)
10.2 Acute Myeloid Leukemia (AML) Therapeutics Key Players in India
10.3 India Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type
10.4 India Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Acute Myeloid Leukemia (AML) Therapeutics Market Size (2016-2020)
11.2 Acute Myeloid Leukemia (AML) Therapeutics Key Players in Central & South America
11.3 Central & South America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type
11.4 Central & South America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application
12 International Players Profiles
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Company Details
12.1.2 Company Description and Business Overview
12.1.3 Acute Myeloid Leukemia (AML) Therapeutics Introduction
12.1.4 Bristol-Myers Squibb Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2020)
12.1.5 Bristol-Myers Squibb Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Acute Myeloid Leukemia (AML) Therapeutics Introduction
12.2.4 Novartis Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2020)
12.2.5 Novartis Recent Development
12.3 Roche
12.3.1 Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Acute Myeloid Leukemia (AML) Therapeutics Introduction
12.3.4 Roche Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2020)
12.3.5 Roche Recent Development
12.4 Genmab
12.4.1 Genmab Company Details
12.4.2 Company Description and Business Overview
12.4.3 Acute Myeloid Leukemia (AML) Therapeutics Introduction
12.4.4 Genmab Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2020)
12.4.5 Genmab Recent Development
12.5 GlaxoSmithKline Pharmaceuticals
12.5.1 GlaxoSmithKline Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Acute Myeloid Leukemia (AML) Therapeutics Introduction
12.5.4 GlaxoSmithKline Pharmaceuticals Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2020)
12.5.5 GlaxoSmithKline Pharmaceuticals Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
List of Tables and Figures
Table Acute Myeloid Leukemia (AML) Therapeutics Key Market Segments
Table Key Players Acute Myeloid Leukemia (AML) Therapeutics Covered
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Market Share by Type 2016-2027
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Radiation therapy Figures
Table Key Players of Radiation therapy
Figure Stem Cell Transplant Figures
Table Key Players of Stem Cell Transplant
Figure Targeted Therapy Figures
Table Key Players of Targeted Therapy
Figure Others Figures
Table Key Players of Others
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Growth by Application 2016-2027 (Million US$)
Figure Hospital Case Studies
Figure Retails Drug Stores Case Studies
Figure Ambulatory Care Centers Case Studies
Figure Oncology Centers Case Studies
Figure Clinics Case Studies
Figure Acute Myeloid Leukemia (AML) Therapeutics Report Years Considered
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size 2016-2027 (Million US$)
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Regions 2016-2027 (Million US$)
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Regions 2016-2020 (Million US$)
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Regions 2016-2020
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Regions 2016-2020
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Regions 2020
Table Market Top Trends
Table Global Acute Myeloid Leukemia (AML) Therapeutics Revenue by Manufacturers (2020) (Million US$)
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Manufacturers (2020)
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Manufacturers in 2020
Table Global Acute Myeloid Leukemia (AML) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Acute Myeloid Leukemia (AML) Therapeutics Product/Solution/Service
Table Date of Enter into Acute Myeloid Leukemia (AML) Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Share by Type (2016-2020)
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Market Share by Type (2016-2020)
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Share by Application (2016-2020)
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Market Share by Application (2016-2020)
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share by Application in 2020
Figure United States Acute Myeloid Leukemia (AML) Therapeutics Market Size 2016-2020 (Million US$)
Table United States Key Players Acute Myeloid Leukemia (AML) Therapeutics Revenue (2020) (Million US$)
Table United States Key Players Acute Myeloid Leukemia (AML) Therapeutics Market Share (2020)
Table United States Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2016-2020) (Million US$)
Table United States Acute Myeloid Leukemia (AML) Therapeutics Market Share by Type (2016-2020)
Table United States Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2016-2020) (Million US$)
Table United States Acute Myeloid Leukemia (AML) Therapeutics Market Share by Application (2016-2020)
Figure Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size 2016-2020 (Million US$)
Table Europe Key Players Acute Myeloid Leukemia (AML) Therapeutics Revenue (2020) (Million US$)
Table Europe Key Players Acute Myeloid Leukemia (AML) Therapeutics Market Share (2020)
Table Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Europe Acute Myeloid Leukemia (AML) Therapeutics Market Share by Type (2016-2020)
Table Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Europe Acute Myeloid Leukemia (AML) Therapeutics Market Share by Application (2016-2020)
Figure China Acute Myeloid Leukemia (AML) Therapeutics Market Size 2016-2020 (Million US$)
Table China Key Players Acute Myeloid Leukemia (AML) Therapeutics Revenue (2020) (Million US$)
Table China Key Players Acute Myeloid Leukemia (AML) Therapeutics Market Share (2020)
Table China Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2016-2020) (Million US$)
Table China Acute Myeloid Leukemia (AML) Therapeutics Market Share by Type (2016-2020)
Table China Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2016-2020) (Million US$)
Table China Acute Myeloid Leukemia (AML) Therapeutics Market Share by Application (2016-2020)
Figure Japan Acute Myeloid Leukemia (AML) Therapeutics Market Size 2016-2020 (Million US$)
Table Japan Key Players Acute Myeloid Leukemia (AML) Therapeutics Revenue (2020) (Million US$)
Table Japan Key Players Acute Myeloid Leukemia (AML) Therapeutics Market Share (2020)
Table Japan Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Japan Acute Myeloid Leukemia (AML) Therapeutics Market Share by Type (2016-2020)
Table Japan Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Japan Acute Myeloid Leukemia (AML) Therapeutics Market Share by Application (2016-2020)
Figure Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Acute Myeloid Leukemia (AML) Therapeutics Revenue (2020) (Million US$)
Table Southeast Asia Key Players Acute Myeloid Leukemia (AML) Therapeutics Market Share (2020)
Table Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Market Share by Type (2016-2020)
Table Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Market Share by Application (2016-2020)
Figure India Acute Myeloid Leukemia (AML) Therapeutics Market Size 2016-2020 (Million US$)
Table India Key Players Acute Myeloid Leukemia (AML) Therapeutics Revenue (2020) (Million US$)
Table India Key Players Acute Myeloid Leukemia (AML) Therapeutics Market Share (2020)
Table India Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2016-2020) (Million US$)
Table India Acute Myeloid Leukemia (AML) Therapeutics Market Share by Type (2016-2020)
Table India Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2016-2020) (Million US$)
Table India Acute Myeloid Leukemia (AML) Therapeutics Market Share by Application (2016-2020)
Figure Central & South America Acute Myeloid Leukemia (AML) Therapeutics Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Acute Myeloid Leukemia (AML) Therapeutics Revenue (2020) (Million US$)
Table Central & South America Key Players Acute Myeloid Leukemia (AML) Therapeutics Market Share (2020)
Table Central & South America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Central & South America Acute Myeloid Leukemia (AML) Therapeutics Market Share by Type (2016-2020)
Table Central & South America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Central & South America Acute Myeloid Leukemia (AML) Therapeutics Market Share by Application (2016-2020)
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2020) (Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Acute Myeloid Leukemia (AML) Therapeutics Business (2020)
Table Bristol-Myers Squibb Recent Development
Table Novartis Company Details
Table Novartis Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2020)(Million US$)
Figure Novartis Revenue Growth Rate in Acute Myeloid Leukemia (AML) Therapeutics Business (2020)
Table Novartis Recent Development
Table Roche Company Details
Table Roche Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2020)(Million US$)
Figure Roche Revenue Growth Rate in Acute Myeloid Leukemia (AML) Therapeutics Business (2020)
Table Roche Recent Development
Table Genmab Company Details
Table Genmab Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2020)(Million US$)
Figure Genmab Revenue Growth Rate in Acute Myeloid Leukemia (AML) Therapeutics Business (2020)
Table Genmab Recent Development
Table GlaxoSmithKline Pharmaceuticals Company Details
Table GlaxoSmithKline Pharmaceuticals Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2020)(Million US$)
Figure GlaxoSmithKline Pharmaceuticals Revenue Growth Rate in Acute Myeloid Leukemia (AML) Therapeutics Business (2020)
Table GlaxoSmithKline Pharmaceuticals Recent Development
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Regions (Million US$) 2021-2027
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Share by Regions (2021-2027)
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Share by Regions in 2027
Figure United States Acute Myeloid Leukemia (AML) Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure China Acute Myeloid Leukemia (AML) Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure Japan Acute Myeloid Leukemia (AML) Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure India Acute Myeloid Leukemia (AML) Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Acute Myeloid Leukemia (AML) Therapeutics Market Size Forecast (2021-2027)(Million USD)
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Product (2021-2027) (Million US$)
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Product (2021-2027)
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Product in 2027
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2021-2027) (Million US$)
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2021-2027)
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources